CD44 and prostate carcinoma: It has been revealed that the tumorigenic prostate cancer stem cells can express specific markers such as telomerase, CD44, CD133, α2β1-integrin, multidrug resistance proteins, aldehyde dehydrogenase, and low or undetectable levels of AR.